• 1
    Mueller DL, Jenkins MK, Schwarz RH. Clonal expansion versus functional clonal inactivation. A costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Ann Rev Immunol 1989; 7: 44580.
  • 2
    Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Ann Rev Immunol 1993; 11: 191212.
  • 3
    Baskar S, Clements VK, Glimcher LH, Nabavi N, Ostrand-Rosenberg S. Rejection of MHC class II-transfected tumor cells requires induction of B7-1 and/or B7-2 costimulatory molecules. J Immunol 1996; 156: 38217.
  • 4
    Gajewski TF, Fallarino F, Uyttenhove C, Boon T. Tumor rejection requires a CTLA-4 ligand by the host or expressed on the tumor. Superiority of B7-1 over B7–2 for active tumor immunization. J Immunol 1996; 156: 290917.
  • 5
    Seo A, Ishikawa F, Nakano H, Nakazaki H, Kobayashi K, Kakiuchi T. Enhancement of B7-1 (CD80) expression on B-lymphoma cells by irradiation. Immunology 1999; 96: 6428.
  • 6
    Ishikawa F, Nakano H, Seo A, Okada Y, Torihata H, Tanaka Y, Uchida T, Miyake H, Kakiuchi T. Irradiation up-regulates CD80 expression through induction of tumor necrosis factor-α and CD40 ligand expression on B lymphoma cells. Immunology 2002; 106: 35462.
  • 7
    Morel A, Fernandez N, De La Coste A, Haddada H, Viguier M, Polla BS, Antoine B, Kahn A. Gamma-ray irradiation induces B7.1 costimulatory molecule neoexpression in various murine tumor cells. Cancer Immunol Immunother 1998; 46: 27782.
  • 8
    Simova J, Reinis M, Sobota V, Capkova J, Bubenik J, Jandlova T. Irradiation of genetically modified plasmacytoma vaccines results in upregulation of CD80 molecule expression, IL-2 production and higher therapeutic efficacy of the vaccines. Folia Biol (Praha) 2000; 46: 115.
  • 9
    Sojka DK, Donepudi M, Bluestone JA, Mokyr MB. Melphalan and other anticancer modalities up-regulate B7–1 gene expression in tumor cells. J Immunol 2000; 164: 62306.
  • 10
    Vereecque R, Buffenoir G, Gonzalez R, Cambier N, Hetuin D, Bauters F, Fenaux P, Quesnel B. Gamma-ray irradiation induces B7.1 expression in myeloid leukemic cells. Br J Haematol 2000; 108: 82531.
  • 11
    Vereecque R, Saudemont A, Wickham TJ, Gonzalez R, Hetuin D, Fenaux P, Quesnel B. Gamma-irradiation enhances transgene expression in leukemic cells. Gene Ther 2003; 10: 22733.
  • 12
    Aoi T, Nakano H, Tanaka Y, Kakiuchi T. Enhancement of antigen-presenting ability of B lymphoma cells by partial inhibition of protein synthesis through inducing B7-1 expression. Immunology 1997; 91: 2128.
  • 13
    Donepudi M, Raychaudhuri P, Blustone JA, Mokyr MB. Mechanism of melphalan-induced B7-1 gene expression in P815 tumor cells. J Immunol 2001; 166: 64919.
  • 14
    Donepudi M, Jovasevic VM, Raychaudhuri P, Mokyr MB. Melphalan-induced up-regulation of B7-1 surface expression on normal splenic B cells. Cancer Immunol Immunother 2003; 52: 16270.
  • 15
    Isobe M, Linsley PS, Ledbetter JA, Nagai Y, Tamakoshi M, Uede T. Identification of an alternatively spliced form of the murine homologue of B7. Biochem Biophys Res Commun 1994; 200: 4439.
  • 16
    Cleveland DW, Lopata MA, MacDonald RJ, Cowan NJ, Rutter WJ, Kirschner MW. Number and evolutionary conversion of α- and γ-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA. Cell 1980; 20: 90105.
  • 17
    Bhattacharya A, Dorf ME, Springer TA. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region duplications. J Immunol 1981; 127: 248895.
  • 18
    Hathcock KS, Laszlo G, Dickler HB, Bradshow J, Linsley P, Hodes RJ. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 1993; 262: 9057.
  • 19
    Dialynas DP, Quan ZSK, Wall A, Pierre A, Quintans J, Loken MR, Pierres M, Fitch FW. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5. Similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol 1983; 131: 244551.
  • 20
    Takei F. Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). J Immunol 1985; 134: 14037.
  • 21
    Sarmiento M, Dialynas DP, Lancki DW, Wall KA, Lorber MI, Loken MR, Fitch FW. Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis. Immunol Rev 1982; 68: 13569.
  • 22
    Razi-Wolf Z, Freeman GJ, Galvin F, Benacerraf B, Nadler L, Reiser H. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudates cells. Proc Natl Acad Sci U S A 1992; 89: 42104.
  • 23
    Kakiuchi T, Mizuguchi J, Nariuchi H. Molecular analysis of the dissociation between IL-2 production and proliferation in a response of a T cell clone to the antigen presented by B cells. J Immunol 1988; 141: 327884.
  • 24
    Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999; 223: 7792.
  • 25
    Watanabe M, Wegmann DR, Ochi A, Hozumi N. Antigen presentation by a B-cell line transfected with cloned immunoglobulin heavy- and light-chain genes specific for a defined hapten. Proc Natl Acad Sci U S A 1986; 83: 524751.
  • 26
    Kakiuchi T, Watanabe M, Hozumi N, Nariuchi H. Differential sensitivity of specific and nonspecific antigen-presentation by B cells to a protein synthesis inhibitor. J Immunol 1990; 145: 16538.
  • 27
    Kokuho T, Nariuchi H, Gyotoku Y, Kakiuchi T. Role of newly synthesized MHC class II molecules in antigen-specific antigen presentation by B cells. Immunobiol 1995; 193: 4258.
  • 28
    Zhao J, Freeman GJ, Gray GS, Nadler LM, Glimcher LH. A cell-type specific enhancer in the human B7–1 gene regulated by NF-κB. J Exp Med 1996; 183: 77789.
  • 29
    Yedidia Y, Ben-Neriah Y, Jung S. Primary B cells essentially lack constitutive NF-κB activity. Eur J Immunol 1998; 28: 306.
  • 30
    Lenshow DJ, Sperling AI, Cooke MP, Freeman G, Rhee L, Decker DC et al. Differential up-regulation of the B7–1 and B7–2 costimulatory molecules after Ig receptor engagement by antigen. J Immunol 1994; 153: 19907.
  • 31
    Kozono Y, Abe R, Kozono H, Kelly RG, Azuma T, Holers VM. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine B cells. J Immunol 1998; 160: 156572.
  • 32
    Ruttrn H, Thiemermann C, Perretti M. Up-regulation of ICAM-1 expression on. J.774.2 macrophages by endotoxin involves activation of NF-κB but not protein tyrosine kinase: comparison to induction of iNOS. Med Inflamm 1999; 8: 7784.
  • 33
    Li J, Liu Z, Jiang S, Cortesini R, Lederman S, Suciu-Foca N. T suppressor lymphocytes inhibit NF-κB-mediated transcription of CD86 gene in APC. J Immunol 1999; 163: 638692.
  • 34
    Hsing Y, Bishop GA. Requirement for nuclear factor-κB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes. J Immunol 1999; 162: 280411.
  • 35
    Sanlioglu S, Williams CM, Samavati L, Butler NS, Wang G, McCray PB Jr et al. Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-α secretion through IKK regulation of NF-κB. J Biol Chem 2001; 276: 3018898.
  • 36
    Hsu HY, Wen MH. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem 2002; 277: 221319.
  • 37
    Woo CH, Eom YW, Yoo MH, You HJ, Han HJ, Song WK et al. Tumor necrosis factor-α generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. J Biol Chem 2000; 275: 3235762.
  • 38
    Pechold K, Patterson NB, Craighead N, Lee KP, June CH, Harlan DM. Inflammatory cytokines IFN-γ plus TNF-α induce regulated expression of CD80 (B7-1) but not CD86 (B7-2) on murine fibroblasts. J Immunol 1997; 158: 49219.
  • 39
    Ranheim EA, Kipps TJ. Tumor necrosis factor-α facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L. Cell Immunol 1995; 161: 22635.
  • 40
    Wykes M, Poudrier J, Lindstedt R, Gray D. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells. Eur J Immunol 1998; 28: 54859.
  • 41
    Claudio E, Brown K, Park S, Wang H, Siebenlist U. BAFF-induced NEMO-independent processing of NF-κB2 in mature B cells. Nat Immunol 2002; 3: 95865.
  • 42
    Coope HJ, Atkinson PGP, Huhse B, Belich M, Janzen J, Holman MJ et al. CD40 regulates the processing of NF-κB2 p100. EMBO J 2002; 20: 537585.
  • 43
    Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Markis C, Li Z-W et al. The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 2002; 17: 52535.
  • 44
    Kayagaki N, Yan M, Seshasayee D, Wang H, Lee W, Trench DM et al. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligands through a discrete surface loop and promotes processing of NF-κB2. Immunity 2002; 17: 51524.
  • 45
    Senftleben U, Li ZW, Baud V, Karin M. IKKβ is essential for protecting T cells from TNFα-induced apoptosis. Immunity 2001; 14: 21730.
  • 46
    Li Q, Sanlioglu S, Li S, Ritchie T, Oberley L, Engelhardt JF. GPx-1 gene delivery modulates NF-κB activation following diverse environmental injuries through a specific subunit of the IKK complex. Antioxid Redox Signal 2001; 3: 41532.
  • 47
    Zajak P, Schutz A, Oertli D, Noppen C, Schaefer C, Heberer M, Spagnoli GC, Marti WR. Enhanced generation of cytotoxic T lymphocytes using recombinant vaccinia virus expressing human tumor-associated antigens and B7 costimulatory molecules. Cancer Res 1998; 54: 56771.
  • 48
    La Motte RN, Sharpe AH, Bluestone AJ, Mokyr MB. Host B7-1 and B7-2 costimulatory molecules contribute to the eradication of B7-1-transfected P815 tumor cells via a CD8+T cell-dependent mechanism. J Immunol 1999; 162: 481723.
  • 49
    Kivekäs I, Hulkkonen J, Hurme M, Vilpo L. CD80 antigen expression as a predictor of ex vivo chemosensitivity in chronic lymphocytic leukemia. Leukemia Res 2002; 26: 4436.